By Kelly Cloonan
Shares of Century Therapeutics climbed after the company announced plans to cut 51% of its employees and focus on programs with the highest potential for value.
The stock rose 11% to $0.61 in after-hours trading on Monday. Shares have declined 75% in the past 12 months through Monday's close.
The company expects to incur charges of about $3.7 million for severance and other employee termination-related costs as a result of the cuts, according to a filing with the Securities and Exchange Commission on Monday.
The reduction in force will amount to about 77 workers, given the company employed 150 full- and part-time employees as of March 1, according to its latest annual filing.
The company expects the layoffs to be substantially complete by the end of the third quarter.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
July 07, 2025 17:55 ET (21:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.